PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing
In association with the Wake Forest Institute for Regenerative Medicine , Phase Holographic Imaging (PHI), BioSpherix , analytics leader SAS and QIAGEN have created a technology development alliance to create the AI-based process control tools needed for automated biomanufacturing — allowing cell-based therapies to be manufactured cost-effectively with superior efficacy and safety.By repairing or replacing dysfunctional cells,